Business Description
Based in Billerica, Massachusetts, and established in 2013, Atlantic International Corp. (which operated as SeqLL Inc. until its name change in June 2024) underwent a significant corporate change on June 18, 2024, when it was acquired by Lyneer Investments, LLC, via a reverse merger. The company operates within the life sciences sector, providing specialized instrumentation and research services. Its primary focus is on generating innovative scientific assets and proprietary intellectual property across various "omics" disciplines. Central to its offerings is the True Single Molecule Sequencing (tSMS) platform. This advanced technology provides a unique single-molecule approach to DNA and RNA sequencing by directly detecting nucleic acids. It empowers researchers to analyze billions of individual molecules within a single experiment, ensuring the generation of highly accurate and reproducible data. Atlantic International's sophisticated solutions cater to diverse applications, including biomarker discovery and the development of diagnostic assays. Its clientele spans academic institutions (such as universities), governmental research centers, and leading companies in the biotechnology and pharmaceutical industries. The company also fosters key collaborations, including an R&D agreement with the U.S. Department of Justice's Federal Bureau of Investigation to assess the forensic potential of direct RNA sequencing using its tSMS platform, and a partnership with the Weizmann Institute of Science to advance and implement cutting-edge single-molecule technologies.
Business History
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -1.08
Total Equity: -$32.09M
Shares: 54,846,155
Total Debt: $86.21M
Cash: $81,134
EBITDA: -$43.64M
Total Debt: $86.21M
Cash: $81,134
Revenue: $435.88M
Shares: 54,846,155
Revenue: $435.88M
Revenue: $435.88M
Revenue: $435.88M
Total Equity: -$32.09M
Tax Rate: -0.1%
Equity: -$32.09M
Total Debt: $86.21M
Cash: $81,134
Current Liabilities: $114.95M
Long-Term Debt: $30.37M
Total Debt: $86.21M
Total Equity: -$32.09M
Shares: 54,846,155
Shares: 54,846,155
CapEx: -$66,768
Shares: 54,846,155
Stock Price: $0.85
Net Income: -$59.43M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 22, 2026 11:50pm (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $425.0M | $441.5M | $401.4M | $442.6M | $435.9M |
| Cost of Revenue | $370.6M | $387.3M | $354.5M | $395.4M | $389.9M |
| Gross Profit | $54.4M | $54.2M | $46.9M | $47.2M | $46.0M |
| Operating Expenses | $90.1M | $48.2M | $50.3M | $69.0M | $96.2M |
| Operating Income | -$35.7M | $6.0M | -$3.5M | -$21.8M | -$50.2M |
| Net Income | -$40.8M | -$3.2M | -$15.3M | -$135.5M | -$59.4M |
| EBITDA | $12.2M | $11.9M | $1.4M | -$113.1M | -$43.6M |
| EPS | $-0.17 | $-0.19 | $-0.60 | $-3.68 | $-1.08 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 22, 2026 11:50pm (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $4.0M | $2.2M | $1.4M | $678,676 | $81,134 |
| Total Current Assets | $10.4M | $6.6M | $78.8M | $88.0M | $81.2M |
| Total Assets | $10.7M | $8.4M | $126.7M | $122.8M | $113.2M |
| Current Liabilities | $2.6M | $1.2M | $161.6M | $97.2M | $115.0M |
| Long-Term Debt | $0 | $1.4M | $980,851 | $36.7M | $30.4M |
| Total Liabilities | $2.6M | $4.0M | $166.0M | $134.8M | $145.3M |
| Total Equity | $8.2M | $4.4M | -$39.4M | -$12.0M | -$32.1M |
| Retained Earnings | -$14.4M | -$18.5M | -$61.8M | -$135.5M | -$194.9M |
Cash Flow (Annual)
Last updated: Jun 22, 2026 11:50pm (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$2.0M | -$3.7M | -$9.1M | -$6.0M | -$4.4M |
| Capital Expenditure | $-14,470 | $-40,020 | $-73,711 | $-73,456 | $-66,768 |
| Free Cash Flow | -$2.0M | -$3.7M | -$9.2M | -$6.1M | -$4.5M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $4.0M | -$1.8M | $-363,234 | $-674,251 | $-597,542 |
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 7:54pm (13h ago)| Metric | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| Revenue |
$442.6M $442.6M – $442.6M
|
$440.2M $440.2M – $440.2M
|
$481.1M $481.1M – $481.1M
|
$37.5M $37.5M – $37.5M
|
| EBITDA |
-$105.9M -$105.9M – -$105.9M
|
-$26.1M -$26.1M – -$26.1M
|
-$28.5M -$28.5M – -$28.5M
|
-$2.2M -$2.2M – -$2.2M
|
| Net Income |
-$691.5M -$691.5M – -$691.5M
|
-$43.9M -$43.9M – -$43.9M
|
-$33.5M -$33.5M – -$33.5M
|
-$636.2M -$636.2M – -$636.2M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 22, 2026 11:50pm (4d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +3.9% | -9.1% | +10.3% | -1.5% |
| Gross Profit Growth | -0.4% | -13.5% | +0.6% | -2.5% |
| Operating Income Growth | +116.7% | -157.7% | -532.6% | -130.1% |
| Net Income Growth | +92.1% | -373.5% | -788.3% | +56.1% |
| EBITDA Growth | -2.0% | -88.0% | -7,973.0% | +61.4% |
Insider Trading (Recent)
Last updated: Jun 27, 2026 4:59am (4h ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-03-12 | PFEFFER DAVID | M-Exempt | 161,290.00 | $0.00 | $0 |
| 2026-03-12 | PFEFFER DAVID | M-Exempt | 161,290.00 | $0.00 | $0 |
| 2026-01-23 | Franke Guus Paul Wilhelm | 0.00 | $0.00 | $0 | |
| 2027-02-02 | Murphy Kevin James | 400,000.00 | $3.46 | $1.4M | |
| 2026-01-05 | Bressman Andrew | M-Exempt | 500,000.00 | $1.33 | $665,000 |
| 2026-01-05 | Bressman Andrew | A-Award | 500,000.00 | $0.00 | $0 |
| 2026-01-07 | Tenore Michael | M-Exempt | 1,202,901.00 | $1.33 | $1.6M |
| 2026-01-05 | Tenore Michael | A-Award | 125,000.00 | $1.33 | $166,250 |
| 2026-01-05 | Evelt Matthew | A-Award | 100,000.00 | $1.33 | $133,000 |
| 2026-01-01 | Jagid Jeffrey M | M-Exempt | 5,551,223.00 | $1.33 | $7.4M |
| 2026-01-05 | Jagid Jeffrey M | A-Award | 1,000,000.00 | $1.33 | $1.3M |
| 2026-01-01 | Tenore Michael | M-Exempt | 264,860.00 | $1.33 | $352,264 |
| 2025-08-11 | Bressman Andrew | 0.00 | $0.00 | $0 | |
| 2025-08-15 | Broderick Christopher | D-Return | 577,171.00 | $0.00 | $58 |
| 2025-08-11 | Tenore Michael | A-Award | 264,860.00 | $0.00 | $26 |
| 2025-08-11 | JAGID JEFFREY M | A-Award | 1,000,000.00 | $0.00 | $100 |
| 2025-08-11 | JAGID JEFFREY M | G-Gift | 400,000.00 | $0.00 | $40 |
| 2025-06-02 | Evelt Matthew | A-Award | 1,000,000.00 | $2.67 | $2.7M |
| 2025-06-01 | Evelt Matthew | 0.00 | $0.00 | $0 | |
| 2025-01-07 | Broderick Christopher | P-Purchase | 577,171.00 | $0.00 | $58 |
Narrative Economics
market-narrative step).